Cargando…

Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing

Detalles Bibliográficos
Autores principales:	Law, Martin, Couturier, Dominique-Laurent, Choodari-Oskooei, Babak, Crout, Phillip, Gamble, Carrol, Jacko, Peter, Pallmann, Philip, Pilling, Mark, Robertson, David S., Robling, Michael, Sydes, Matthew R., Villar, Sofía S., Wason, James, Wheeler, Graham, Williamson, S. Faye, Yap, Christina, Jaki, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664262/ https://www.ncbi.nlm.nih.gov/pubmed/37990330 http://dx.doi.org/10.1186/s13063-023-07763-6

Ejemplares similares

Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing
por: Law, Martin, et al.
Publicado: (2023)

Adaptive designs in clinical trials: why use them, and how to run and report them
por: Pallmann, Philip, et al.
Publicado: (2018)

Point estimation for adaptive trial designs II: practical considerations and guidance
por: Robertson, David S., et al.
Publicado: (2023)

Point estimation for adaptive trial designs I: A methodological review
por: Robertson, David S., et al.
Publicado: (2022)

A Bayesian adaptive design for clinical trials in rare diseases
por: Williamson, S. Faye, et al.
Publicado: (2017)

Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
por: Wason, James M. S., et al.
Publicado: (2022)

Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
por: Wilson, Nina, et al.
Publicado: (2021)

Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
por: Burnett, Thomas, et al.
Publicado: (2020)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses
por: Williamson, S. Faye, et al.
Publicado: (2022)

Combined test versus logrank/Cox test in 50 randomised trials
por: Royston, Patrick, et al.
Publicado: (2019)

A third trial oversight committee: Functions, benefits and issues
por: Lane, J Athene, et al.
Publicado: (2019)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
por: Royston, Patrick, et al.
Publicado: (2011)

Prospective reporting of statistical analysis plans for randomised controlled trials
por: Hemming, Karla, et al.
Publicado: (2020)

An ethnographic study of group decision making to understand and improve how trial steering committees contribute to trial conduct
por: Daykin, Anne, et al.
Publicado: (2013)

Legislation and standards of the European Agency for Safety and Health at Work
por: European Agency for Safety and Health at Work. Bilbao
Publicado: (2000)

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate
por: Morris, Tim P, et al.
Publicado: (2019)

Risk-adapted approaches to the management of clinical trials: guidance from the Department of Health (DH)/Medical Research Council(MRC)/Medicines and Healthcare Products Regulatory Agency (MHRA) Clinical Trials Working Group
por: Meredith, Sarah, et al.
Publicado: (2011)

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
por: Jaki, Thomas, et al.
Publicado: (2018)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials
por: Conroy, Elizabeth J., et al.
Publicado: (2017)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)

Online error rate control for platform trials
por: Robertson, David S., et al.
Publicado: (2023)

The extension of total gain (TG) statistic in survival models: properties and applications
por: Choodari-Oskooei, Babak, et al.
Publicado: (2015)

What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges
por: Daykin, Anne, et al.
Publicado: (2016)

Designing and evaluating dose-escalation studies made easy: The MoDEsT web app
por: Pallmann, Philip, et al.
Publicado: (2019)

Evidence base for patient and public involvement in clinical trials (EPIC)
por: Gamble, Carrol, et al.
Publicado: (2013)

Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently
por: White, Ian R, et al.
Publicado: (2022)

Legislation for trial registration and data transparency
por: Bian, Zhao-Xiang, et al.
Publicado: (2010)

Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats
por: Lee, Kim May, et al.
Publicado: (2021)

Costs and consequences of the Family Nurse Partnership (FNP) programme in England: evidence from the Building Blocks trial
por: Bell, Kerry, et al.
Publicado: (2019)

Review and evaluation of performance measures for survival prediction models in external validation settings
por: Rahman, M. Shafiqur, et al.
Publicado: (2017)

A mapping and gapping analysis of patient and public involvement in a clinical trials unit
por: Bagley, Heather, et al.
Publicado: (2013)

Implementation of the Family Nurse Partnership programme in England: experiences of key health professionals explored through trial parallel process evaluation
por: Sanders, J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5e9j2v98i2hecvllcm1j2geu7f